Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8248 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8079 |
Intermediate Similarity |
NPD37 |
Approved |
0.8052 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD228 |
Approved |
0.7971 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7945 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7922 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7922 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7899 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7887 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7887 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7843 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7832 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7812 |
Intermediate Similarity |
NPD7228 |
Approved |
0.781 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7762 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7703 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7677 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7671 |
Intermediate Similarity |
NPD9570 |
Approved |
0.7671 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.764 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7626 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7593 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7578 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7569 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7467 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD826 |
Approved |
0.7448 |
Intermediate Similarity |
NPD825 |
Approved |
0.744 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7413 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD3705 |
Approved |
0.741 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7391 |
Intermediate Similarity |
NPD17 |
Approved |
0.7386 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7386 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7386 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7379 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7357 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7348 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7348 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7279 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7273 |
Intermediate Similarity |
NPD258 |
Approved |
0.7273 |
Intermediate Similarity |
NPD257 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7266 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD943 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD6362 |
Approved |
0.7203 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7194 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7194 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7185 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD555 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD259 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7103 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD2240 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2239 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7083 |
Intermediate Similarity |
NPD987 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7075 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7071 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7071 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7068 |
Intermediate Similarity |
NPD290 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7027 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD7972 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7018 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7018 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1607 |
Approved |
0.6993 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6992 |
Remote Similarity |
NPD3134 |
Approved |
0.6988 |
Remote Similarity |
NPD5242 |
Approved |
0.6986 |
Remote Similarity |
NPD9569 |
Approved |
0.6986 |
Remote Similarity |
NPD5736 |
Approved |
0.6983 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.698 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD5712 |
Approved |
0.6974 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD1203 |
Approved |
0.6962 |
Remote Similarity |
NPD5403 |
Approved |
0.6959 |
Remote Similarity |
NPD3144 |
Approved |
0.6959 |
Remote Similarity |
NPD411 |
Approved |
0.6959 |
Remote Similarity |
NPD3764 |
Approved |
0.6959 |
Remote Similarity |
NPD3145 |
Approved |
0.6957 |
Remote Similarity |
NPD2629 |
Approved |
0.6951 |
Remote Similarity |
NPD919 |
Approved |
0.6948
|
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |